Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 8, 2008, Pages 759-766

  Midzi, N ^a   Sangweme, D ^b   Zinyowera, S ^c   Mapingure, M P ^d   Brouwer, K C ^e   Kumar, N ^b   Mutapi, F ^f   Woelk, G ^d   Mduluza, T ^d  

^a NATIONAL INSTITUTE OF HEALTH RESEARCH   (Zimbabwe)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UZ College of Health Sciences   (Zimbabwe)

^d UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Efficacy; Praziquantel; Schistosoma haematobium; School children; Treatment; Zimbabwe

Indexed keywords

PRAZIQUANTEL;

ADOLESCENT; ARTICLE; CHILD; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ELEMENTARY STUDENT; ENDEMIC DISEASE; FACE EDEMA; FECES CULTURE; FEMALE; FOLLOW UP; HUMAN; LETHARGY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIMARY SCHOOL; PRURITUS; RURAL HEALTH CARE; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SCHOOL HEALTH SERVICE; SEX DIFFERENCE; SINGLE DRUG DOSE; SOMNOLENCE; STOMACH DISCOMFORT; TREATMENT DURATION; URINALYSIS; VOMITING; ZIMBABWE;

ADOLESCENT; ANIMALS; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ENDEMIC DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; PARASITE EGG COUNT; PRAZIQUANTEL; RURAL HEALTH; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS HAEMATOBIA; TREATMENT OUTCOME; ZIMBABWE;

SCHISTOSOMA HAEMATOBIUM;

EID: 46249104637     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.03.010     Document Type: Article

References (44)

1. Alonso D., Munoz J., Gascon J., Valls E.M., and Corachan M. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am. J. Trop. Med. Hyg. 74 (2006) 342-344
2. Brouwer K.C., Ndhlovu P.D., Munatsi A., and Shiff C.J. Genetic diversity of a population of Schistosoma haematobium derived from school children in east central Zimbabwe. J. Parasitol. 87 (2001) 762-769
3. Butterworth A.E., Sturrock R.F., Ouma J.H., Mbugua G.G., Fulford A.J., Kariuki H.C., and Koech D. Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity. Parasitology 103 (1991) 339-355
4. Cheesbrough M. Formal ether concentration technique, in: District Laboratory Practice in Tropical Countries Part 1 (1998), Tropical Health Technology, Cambridge pp. 197-199
5. Cioli D. Praziquantel: is there real resistance and are there alternatives? Curr. Opin. Infect. Dis. 13 (2000) 659-663
6. Crompton D.W.T., Montresor A., Nesheim M.C., and Savioli L. Controlling Disease due to Helminth Infection (2003), World Health Organization, Geneva
7. Danso-Appiah A., and De Vlas S.J. Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends Parasitol. 18 (2002) 125-129
8. de Clercq D., Vercruysse J., Kongs A., Verle P., Dompnier J.P., and Faye P.C. Efficacy of artesunate and praziquantel in Schistosoma haematobium infected schoolchildren. Acta Trop. 82 (2002) 61-66
9. Engels D., Sinzinkayo E., and Gryseels B. Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications. Am. J. Trop. Med. Hyg. 54 (1996) 319-324
10. Feldmeier H., Poggensee G., Krantz I., and Helling-Giese G. Female genital schistosomiasis as a risk factor for HIV transmission. Int. J. STD AIDS 5 (1994) 368-372
11. Fenwick A., and Webster J.P. Schistosomiasis: challenges for control, treatment and drug resistance. Curr. Opin. Infect. Dis. 19 (2006) 577-582
12. Fenwick A., Savioli L., Engels D., Bergquist N.R., and Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 19 (2003) 509-515
13. Ferrari M.L., Coeho P.M., Antunes C.M., Tavares C.A., and da Cunha A.S. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial. Bull. World Health Organ. 81 (2003) 190-196
14. Gryseels B., Nkulikyinka L., and Coosemans M.H. Field trials of praziquantel and oxamniquine for the treatment of Schistosoma mansoni in Burundi. Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 641-644
15. Gryseels B., Mbaye A., De Vlas S.J., Stelma F.F., Guisse F., Van Lieshout L., Faye D., Diop M., Ly A., Tchuem-Tchuente L.A., Engels D., and Polman K. Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Trop. Med. Int. Health 6 (2001) 864-873
16. Ismail M., Botros S., Metwally A., William S., Farghally A., Tao L.F., Day T.A., and Bennett J.L. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60 (1999) 932-935
17. Kabatereine N.B., Kimijumbi J., Ouma J.H., Sturock R.F., Butterworth A.E., Madsen H., Ornbjerg N., Dunne D.W., and Vennervald B.J. Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 599-603
18. Katz N., Chaves A., and Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosoma mansoni. Rev. Inst. Med. Trop. Sao Paulo 14 (1972) 397-400
19. Kimura E., Kamou G.M., Kiliku F.M., Muhoho N.D., Waiyaki P.G., Simoda M., and Aoki Y. Side effects of praziquantel in the treatment of urinary schistosomiasis in Kenya. Trop. Med. 34 (1992) 91-96
20. King C.H., Muchiri E.M., and Ouma J.H. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerg. Infect. Dis. 6 (2000) 585-594
21. Lawn S., Lucas S., and Chiodini P. Schistosoma mansoni infection: failure of standard treatment with praziquantel in a returned traveler. Trans. R. Soc. Trop. Med. Hyg. 97 (2003) 100-101
22. Mduluza T., Ndhlovu P.D., Madziwa T.M., Midzi N., Zinyama R., Turner C.M., Chandiwana S.K., Nyazema N., and Hagan P. The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection. Mem. Inst. Oswaldo Cruz 96 Suppl. (2001) 157-164
23. Mott K.E., Baltes R., Bambagha J., and Baldassini B. Field studies of a reusable polyamide filter for detection of Schistosoma haematobium eggs by urine filtration. Tropenmed. Parasitol. 3 (1982) 227-228
24. N'Goran E.K., Gnaka H.N., Tanner M., and Utzinger J. Efficacy and side effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire. Ann. Trop. Med. Parasitol. 97 (2003) 37-51
25. Picquet M., Vercruysse J., Shaw D.J., Diop M., and Ly A. Efficacy of praziquantel against Schistosoma mansoni in Northern Senegal. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 90-93
26. Raso G., N'Goran E.K., Toty A., Luginbuhl A., Adjoua C.A., Tian-Bi N.T., Bogoch I.I., Vounatsou P., Tanner M., and Utzinger J. Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire. Trans. R. Soc. Trop. Med. Hyg. 98 (2004) 18-27
27. Renganathan E., and Cioli D. An international initiative on praziquantel use. Parasitol. Today 14 (1998) 390-391
28. Rollinson D., and Southgate R. The genus Schistosoma: a taxonomic appraisal. In: Rollinson D., and Simpson A.J.G. (Eds). The Biology of Schistosomes from Genes to Latrines (1987), Academic Press, San Diego 1-49
29. Sabah A.A., Fletcher C., Webbe G., and Doenhoff M. Schistosoma mansoni: chemotherapy of infections of different ages. Exp. Parasitol. 61 (1986) 294-303
30. Shiff C.J., Brouwer K.C., and Clow L. Schistosoma haematobium: population genetics of S. haematobium by direct measurement of parasite diversity using RAPD PCR. Exp. Parasitol. 96 (2000) 47-51
31. Stelma F.F., Talla I., Sow S., Kongs A., Niang M., Polman K., Deelder A.M., and Gryseels B. Efficacy and side effects of praziquantel in an epidemic focus of Schistosoma mansoni. Am. J. Trop. Med. Hyg. 53 (1995) 167-170
32. Taylor P., and Makura O. Prevalence and distribution of schistosomiasis in Zimbabwe. Ann. Trop. Med. Parasitol. 79 (1985) 287-299
33. Taylor P., Murare H.M., and Manomano K. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium. J. Trop. Med. Hyg. 91 (1988) 13-17
34. Triggle D.J. Stereoselectivity of drug action. Drug Discov. Today 2 (1997) 138-147
35. Utzinger J., N'Goran E.K., N'Dri A., Lengeler C., and Tanner M. Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop. Med. Int. Health 5 (2000) 771-778
36. Utzinger J., Booth M., N'Goran E.K., Muller I., Tanner M., and Lengeler C. Relative contribution of day-to-day and intra-specimen variation in faecal egg counts of Schistosoma mansoni before and after treatment with praziquantel. Parasitology 122 (2001) 537-544
37. Utzinger J., Keiser J., Shuhua X., Tanner M., and Singer B.H. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob. Agents Chemother. 47 (2003) 1487-1495
38. Webbe G., and James C. A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters. Parasitol. Res. 52 (1977) 169-177
39. WHO, 2002a. The Prevention and Control of Schistosomiasis and Soil Transmitted Helminthiasis. Report of a WHO Expert Committee. World Health Organization, Geneva, WHO Technical Report Series No. 912.
40. WHO, 2002b. Report of the Informal Consultation on the Use of Praziquantel During Pregnancy/Lactation and Albendazole/Mebendazole in Children Under 24 Months. World Health Organization, Geneva, WHO/CDC/CPE/PVC/2002.4.
41. WHO. Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiasis (2004), World Health Organization, Geneva WHO/CDC/CPE/PVC/2004.9
42. WHO, 2005. Scientific Working Group Report on Schistosomiasis. World Health Organization, Geneva, WHO/TDR/SWG/07.
43. World Health Assembly. Schistosomiasis and Soil-Transmitted Helminth Infections (2001), WHA A54/VR/9
44. Xiao S.H., Yue W.J., Yang Y.Q., and You J.Q. Susceptibility of Schistosoma japonicum to different developmental stages to praziquantel. Chin. Med. J. 100 (1987) 759-768